Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms

ClinicalTrials.gov ID: NCT05407064

Public ClinicalTrials.gov record NCT05407064. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multi-center, Randomized, Double-Blind, Parallel-Group, Dose-Finding Study to Assess the Effect of Four Doses of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms

Study identification

NCT ID
NCT05407064
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Definium Therapeutics US, Inc.
Industry
Enrollment
198 participants

Conditions and interventions

Interventions

  • MM120 Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 74 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 23, 2022
Primary completion
Oct 5, 2023
Completion
Nov 26, 2023
Last update posted
Feb 26, 2026

2022 – 2023

United States locations

U.S. sites
22
U.S. states
13
U.S. cities
21
Facility City State ZIP Site status
Preferred Research Partners Little Rock Arkansas 72211
Irvine Center for Clinical Research Irvine California 92614
Kadima Neuropsychiatry Institute La Jolla California 92037
Pacific Neuroscience Institute Santa Monica California 90404
Mountain View Clinical Research Denver Colorado 80209
Wholeness Center Fort Collins Colorado 80525
Segal Trials Lauderhill Florida 33319
CNS Healthcare - Orlando Orlando Florida 32801
iResearch Atlanta Decatur Georgia 30030
Great Lakes Clinical Trials Chicago Illinois 60640
Uptown Research Chicago Illinois 60640
Sunstone Therapies Rockville Maryland 20850
SISU Springfield Massachusetts 01103
Adams Clinical Watertown Massachusetts 02472
Hassman Research Institute Berlin New Jersey 08009
GMI - Princeton Medical Institute Princeton New Jersey 08540
Lutheran Hospital - Cleveland Clinic Cleveland Ohio 44113
BioBehavioral Research of Austin Austin Texas 78759
University of Texas Health Houston Houston Texas 77054
Cedar Clinical Research Draper Utah 84020
Cedar Clinical Research - Murray Murray Utah 84107
Woodstock Research Center Woodstock Vermont 05091

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05407064, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 26, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05407064 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →